Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Tuesday, February 24, 2009

2007 paper : Monell Senses Center : Trimethylaminuria in a sample of body odor and halitosis visitors

Medical Paper 2007: Human breath odors and their use in diagnosis.

Whittle CL, Fakharzadeh S, Eades J, Preti G

Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA.

This is probably the current medical 'signature' paper on the concept of systemic body odor, albeit, it seems as if they only accept trimethylaminuria in regards of this concept, and possibly will historically be seen as an interim paper until serious research into systemic odors is conducted broadly by the medical community. The paper is thought-provoking nevertheless, but unfortunately the full paper is not available free. If anything, it shows how far off we are to understanding fecal body odor and such types of systemic odor problems which seem to be the most common type on the body odor forums. An especially interesting point is that out of all those who attended the Monell Center in the paper (300+); of the 102 who went on to fail the TMAU urine test, it seems very few could be smelt (10% ? after the choline challenge ?), and of the 6 who done a certain group of tests, only the 2 with the severe TMAU smelt of fish (?). It isn't clear exactly was meant in these statements, and would need to be clarified.
...In our population, all of whom have been seen in person, the fish odor presentation was present in only about 10% of individuals who
are TMAU-positive. Further to this point, these individuals emitted a strong fish odor recognizable at social distances only after choline challenge...

... TMAU is known to be caused by a “spectrum” of genetic changes to the gene that codes for FMO3. Consequently, this variation may be due, in part, to differences in the genotype of each of the TMAU-positive individuals. This is supported by our clinical observations regarding the odor of different individuals as well as genotyping data. Two of the six TMAU-positive individuals whose saliva was analyzed presented with overt fish odor from their upper body and oral cavity after (∼22 h) choline challenge. As noted above, each of these male subjects had a low conversion of TMA to TMAO (<25%)

Amongst other things, this paper eludes as to how the odor in TMAU varies in type of odor as well as in its inconsistent manifestation, since it may be sporadic. This intermittent presentation frequently results in the sufferer being referred to a psychiatrist when family members or physicians at times don’t smell the odor, and therefore arrive at the conclusion that the sufferer has developed an Olfactory Reference Syndrome. This seems to be the biggest source of conflict between sufferers and their families and or physicians.
TMA is a gas at body temperature and has a foul, rotten fish odor. At low concentrations it may be perceived as unpleasant or garbage-like...The main difficulties experienced by TMAU-affected individuals are psychosocial ones that are caused by sporadic, undiagnosed odor production.
They mention that a 'fish odor' for trimethylaminuria is not always correct, and that it can vary . The discussion section of this paper (page 10) states,
Consequently, the assumption that the individual with TMAU will always smell "like fish" is incorrect and is often the reason that many TMAU-affected individuals are sent from one clinical specialist to another: quite often they are sent to a psychiatrist since their reported symptoms are thought to be subjective.
On the Monell website, they mention trimethylaminuria causing other smells, but not fecal or gas odor. It's up to each reader as to how to interpret this omission of what seem the most common smells on the body odor forums.
TMA has a foul, fishy odor. At low concentrations, it may be perceived as unpleasant or “garbage-like.” (pdf download)


Post a Comment